SameerAshokParikhMD

PubMed

• Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era.
  Paul J Hampel, Kari G Rabe, Yucai Wang, Steven R Hwang, Saad S Kenderian
  Leukemia. 2024-12-10
• Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell Lymphocytosis.
  Bryan A Vallejo, Ahmed Ansari, Sameer A Parikh, Sara J Achenbach, Kari G Rabe
  Journal of Clinical Oncology. 2024-12-10
• Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL).
  Aswin Sekar, Rosalie Griffin, Sameer A Parikh, Giulio Genovese, Dennis P Robinson
  Blood Cancer Journal. 2024-11-06

Journal Articles

• Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical Centre  
  Sameer A Parikh, Tait D Shanafelt, Paul J Hampel, Jose F Leis, Neil E Kay, Wei Ding, Timothy G Call, Deborah Bowen, Eli Muchtar, British Journal of Haematology

Abstracts/Posters

• Targeting Cancer Associated Fibroblasts in the Bone Marrow Prevents Resistance to Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma
  Sameer A. Parikh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Circulating Extracellular Vesicles Induce Chimeric Antigen Receptor T Cell Dysfunction in Chronic Lymphocytic Leukemia (CLL)
  Sameer A. Parikh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Improved Anti-Tumor Response of Chimeric Antigen Receptor T Cell (CART) Therapy after GM-CSF Inhibition is Mechanistically Supported By a Novel Direct Interaction of G...
  Sameer A. Parikh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis
  Sameer A. Parikh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Primary Analysis of Anti-CD19 Tafasitamab (MOR208) Treatment in Combination with Idelalisib or Venetoclax in R/R CLL Patients Who Failed Prior BTK Inhibitor Therapy (C...
  Sameer A. Parikh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Role for TNF-_ in Chronic Lymphocytic Leukemia Bone Marrow Hematopoietic Dysfunction
  Sameer A. Parikh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Tumor Mutational Load and Germline Polygenic Risk Score Predicts Time-to-First Treatment in Chronic Lymphocytic Leukemia (CLL) and High-Count Monoclonal B Cell Lymphoc...
  Sameer A. Parikh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of Progression
  Sameer A. Parikh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Development of a Sensitive and Efficient Reporter Platform for the Detection of Chimeric Antigen Receptor T Cell Expansion, Trafficking, and Toxicity
  Sameer A. Parikh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Developmental DNA Methylation Subtype Predicts Progression to Treatment and Survival in High-Count Monoclonal B Lymphocytosis
  Sameer A. Parikh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• A Randomized Phase 2 Study Comparing Acalabrutinib with or without Obinutuzumab in the Treatment of Early Stage High Risk Patients with Chronic Lymphocytic Leukemia (C... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Chronic Lymphocytic Leukemia (CLL) Transformed into Hodgkin Lymphoma (HL): Clinical Characteristics and Outcomes from a Large Multi-Center Collaboration 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Size Matters: Identification of Larger Size CD19 Positive Extracellular Vesicles in Chronic Lymphocytic Leukemia That Inhibit Chimeric Antigen Receptor T Cell Functions 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Size Matters: Identification of Larger Size CD19 Positive Extracellular Vesicles in Chronic Lymphocytic Leukemia That Inhibit Chimeric Antigen Receptor T Cell Functions 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all